Health-Related Quality of Life in Patients With Systemic Autoimmune Rheumatic Diseases (SARD) and Post-COVID Syndrome: A Case-Control Study.

Publication date: Jun 01, 2025

To assess the prevalence and characteristics of the post-COVID syndrome and its effect on the health-related quality of life (HRQOL) of COVID-19-recovered patients with SARD. This cross-sectional study included patients over 18 years old with systemic autoimmune rheumatic diseases (SARDs) in addition to sex- and age-matched controls without SARDs who tested positive for SARS-CoV-2. Sociodemographic variables and clinical data related to the infection and its severity were collected using EuroQol-5 dimensions-5 levels (EQ-5D-5L) and EuroQol-visual analogue scales (EQ-VAS). We included 58 patients with SARD and 116 controls. Post-COVID syndrome was observed in 39 (67. 2%) of SARD patients and 86. 2% of the controls (p

Concepts Keywords
18years Adult
5d Aged
Autoimmune Autoimmune Diseases
Covid Case-Control Studies
Recovered COVID-19
Cross-Sectional Studies
Fatigue
Female
Humans
Male
Middle Aged
Post-Acute COVID-19 Syndrome
post‐COVID syndrome
Quality of Life
quality of life
Rheumatic Diseases
SARS-CoV-2

Semantics

Type Source Name
disease IDO quality
disease MESH Rheumatic Diseases
disease MESH Syndrome
disease MESH COVID-19
disease MESH infection
disease MESH Long Covid
disease MESH Autoimmune Diseases

Original Article

(Visited 1 times, 1 visits today)